0001213900-21-010414.txt : 20210218 0001213900-21-010414.hdr.sgml : 20210218 20210218190209 ACCESSION NUMBER: 0001213900-21-010414 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210216 FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COLEMAN KIRK ALLEN CENTRAL INDEX KEY: 0001790624 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39102 FILM NUMBER: 21651320 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1973 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 ownership.xml X0306 4 2021-02-16 0 0001733413 TFF Pharmaceuticals, Inc. TFFP 0001790624 COLEMAN KIRK ALLEN 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 0 1 0 0 CFO, Secretary and Treasurer Common Stock 2021-02-16 4 M 0 5000 2.50 A 6000 D Common Stock 2021-02-16 4 S 0 5000 16.82 D 1000 D Stock Options (Right to Buy) 2.5 2021-02-16 4 M 0 5000 0.00 D 2020-04-11 2029-04-11 Common Stock 5000 282883 D The transactions reported by this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020. The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options. 37,500 shares of common stock vested on April 11, 2020 and the remainder of the shares vested at an approximate rate of 9,375 every three months thereafter. /s/ Kirk Allen Coleman 2021-02-18